{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:12:22Z","timestamp":1793146342421,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.isci.2024.109179","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T12:41:07Z","timestamp":1707482467000},"page":"109179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics"],"prefix":"10.1016","volume":"27","author":[{"given":"Meenakshi","family":"Anurag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Strandgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchao","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comperat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmat","family":"Al-Ahmadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brant A.","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Taber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iver","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Bjerggaard","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Dyrskj\u00f8t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6379-2581","authenticated-orcid":false,"given":"Seth P.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.109179_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/MOU.0000000000000093","article-title":"New imaging techniques for nonmuscle invasive bladder cancer","volume":"24","author":"von Rundstedt","year":"2014","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.isci.2024.109179_bib2","first-page":"596","article-title":"Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm","year":"1992","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2024.109179_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","article-title":"Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer","volume":"174","author":"Robertson","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.109179_bib4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00000478-200103000-00010","article-title":"Morphologic expressions of urothelial carcinoma in\u00a0situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in\u00a0situ with microinvasion","volume":"25","author":"McKenney","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.isci.2024.109179_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.isci.2024.109179_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2024.109179_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2005.06.135","article-title":"High-grade Ta urothelial carcinoma and carcinoma in\u00a0situ of the bladder","volume":"66","author":"Sylvester","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.isci.2024.109179_bib8","first-page":"1124","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in\u00a0situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2024.109179_bib9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2012.10.039","article-title":"Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guerin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance","volume":"63","author":"Oddens","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2024.109179_bib10","first-page":"74","article-title":"Clinical outcomes of primary bladder carcinoma in\u00a0situ in a contemporary series","volume":"184","author":"Chade","year":"2010","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.isci.2024.109179_bib11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2022.09.008","article-title":"Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guerin Failure in Patients with Non-muscle-invasive Bladder Cancer","volume":"82","author":"Strandgaard","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2024.109179_bib12","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.109179_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.109179_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A Consensus Molecular Classification of Muscle-invasive Bladder Cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2024.109179_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2024.109179_bib16","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-03-3620","article-title":"Gene expression in the urinary bladder: a common carcinoma in\u00a0situ gene expression signature exists disregarding histopathological classification","volume":"64","author":"Dyrskj\u00f8t","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2024.109179_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab186","article-title":"Strand Orientation Bias Detector to determine the probability of FFPE sequencing artifacts","volume":"22","author":"Diossy","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.isci.2024.109179_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109179_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAP.0000000000000239","article-title":"Urothelial Carcinoma In Situ (CIS): New Insights","volume":"26","author":"Akhtar","year":"2019","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.isci.2024.109179_bib20","article-title":"A Comprehensive Bioinformatics Analysis of Notch Pathways in Bladder Cancer","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2024.109179_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.eururo.2015.07.009","article-title":"Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer","volume":"68","author":"Plimack","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2024.109179_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fgene.2018.00254","article-title":"Pan-Cancer Analysis Reveals the Functional Importance of Protein Lysine Modification in Cancer Development","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.isci.2024.109179_bib23","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/s41418-019-0278-9","article-title":"Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer","volume":"26","author":"Ramakrishnan","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.isci.2024.109179_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12885-021-08372-9","article-title":"Significance of KDM6A mutation in bladder cancer immune escape","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2024.109179_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccell.2017.08.005","article-title":"Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency","volume":"32","author":"Hurst","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2024.109179_bib26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.15252\/msb.20167490","article-title":"Integration of over 9,000 mass spectrometry experiments builds a global map of human protein complexes","volume":"13","author":"Drew","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.isci.2024.109179_bib27","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/cncr.22588","article-title":"PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression","volume":"109","author":"Inman","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2024.109179_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.109179_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.isci.2024.109179_bib30","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109179_bib31","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.109179_bib32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/biostatistics\/kxm049","article-title":"Penalized loss functions for Bayesian model comparison","volume":"9","author":"Plummer","year":"2008","journal-title":"Biostatistics"},{"key":"10.1016\/j.isci.2024.109179_bib33","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","volume":"4","author":"Li","year":"2013","journal-title":"arXiv"},{"key":"10.1016\/j.isci.2024.109179_bib34","article-title":"Calling Somatic SNVs and Indels with Mutect2","volume":"4","author":"Benjamin","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2024.109179_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"10.1016\/j.isci.2024.109179_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/modpathol.2014.139","article-title":"BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children","volume":"28","author":"Peters","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.isci.2024.109179_bib37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2019.02.017","article-title":"The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability","volume":"75","author":"Kim","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.isci.2024.109179_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.euo.2022.01.008","article-title":"Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer","volume":"5","author":"Taber","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.isci.2024.109179_bib39","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1038\/s41467-020-18640-0","article-title":"Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis","volume":"11","author":"Taber","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.109179_bib40","doi-asserted-by":"crossref","first-page":"W130","DOI":"10.1093\/nar\/gkx356","article-title":"WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109179_bib41","doi-asserted-by":"crossref","first-page":"W77","DOI":"10.1093\/nar\/gkt439","article-title":"WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013","volume":"41","author":"Wang","year":"2013","journal-title":"Nucleic Acids Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224004000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224004000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:52:17Z","timestamp":1753869137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224004000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2589004224004000"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.109179","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.109179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109179"}}